Unigestion Holding SA purchased a new stake in MetLife, Inc. (NYSE:MET - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 9,606 shares of the financial services provider's stock, valued at approximately $792,000.
Several other hedge funds and other institutional investors have also made changes to their positions in MET. TD Private Client Wealth LLC grew its holdings in MetLife by 5.5% during the third quarter. TD Private Client Wealth LLC now owns 63,587 shares of the financial services provider's stock valued at $5,245,000 after purchasing an additional 3,314 shares during the period. Coldstream Capital Management Inc. boosted its position in shares of MetLife by 7.1% during the third quarter. Coldstream Capital Management Inc. now owns 19,420 shares of the financial services provider's stock worth $1,602,000 after purchasing an additional 1,280 shares in the last quarter. MidWestOne Financial Group Inc. boosted its position in shares of MetLife by 13.4% during the third quarter. MidWestOne Financial Group Inc. now owns 37,648 shares of the financial services provider's stock worth $3,105,000 after purchasing an additional 4,445 shares in the last quarter. Brophy Wealth Management LLC bought a new stake in shares of MetLife in the 3rd quarter valued at $243,000. Finally, LRI Investments LLC raised its stake in MetLife by 308.7% during the 3rd quarter. LRI Investments LLC now owns 989 shares of the financial services provider's stock worth $82,000 after buying an additional 747 shares during the period. 89.81% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of research analysts have issued reports on MET shares. TD Cowen boosted their target price on MetLife from $97.00 to $99.00 and gave the company a "buy" rating in a research note on Wednesday, November 27th. Wells Fargo & Company boosted their price objective on MetLife from $92.00 to $93.00 and gave the company an "overweight" rating in a research report on Tuesday, November 5th. Piper Sandler raised their target price on shares of MetLife from $85.00 to $92.00 and gave the stock an "overweight" rating in a report on Wednesday, October 2nd. StockNews.com upgraded shares of MetLife from a "hold" rating to a "buy" rating in a report on Monday, November 25th. Finally, Jefferies Financial Group raised their price objective on shares of MetLife from $89.00 to $95.00 and gave the stock a "buy" rating in a report on Friday, September 27th. Fourteen equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, MetLife has a consensus rating of "Buy" and a consensus price target of $88.62.
Read Our Latest Research Report on MET
MetLife Stock Up 3.6 %
Shares of NYSE:MET traded up $2.89 during midday trading on Thursday, reaching $83.22. The company had a trading volume of 6,466,464 shares, compared to its average volume of 3,330,530. The business's 50 day moving average price is $83.75 and its 200 day moving average price is $77.22. MetLife, Inc. has a 1-year low of $64.61 and a 1-year high of $89.05. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. The stock has a market cap of $57.62 billion, a PE ratio of 16.20, a P/E/G ratio of 0.78 and a beta of 1.06.
MetLife Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Tuesday, November 5th will be paid a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.62%. The ex-dividend date of this dividend is Tuesday, November 5th. MetLife's dividend payout ratio is currently 43.95%.
MetLife Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.